Fw: Pfizer's Warner-Lambert Probed on Neurontin Marketing

[Guest guest]

----- Original Message -----

From: " ilena rose " <ilena@...>

<Recipient List Suppressed:;>

Sent: Monday, March 25, 2002 11:41 PM

Subject: Pfizer's Warner-Lambert Probed on Neurontin Marketing

> http://www.medscape.com/viewarticle/430081?srcmp=3Dpsy-031502

>

>

> March 26, 2002

>

>

> Pfizer's Warner-Lambert Probed on Neurontin Marketing

>

> NEW YORK (Reuters) Mar 14 - A former employee has accused drugmaker

> Warner-Lambert, acquired by Pfizer Inc. in 2000, of aggressively marketing

> the anticonvulsant Neurontin (gabapentin) to physicians for more than a

> dozen medical conditions for which it was not approved, the New York Times

> reported on Thursday.

>

> lin, a former research fellow at Harvard Medical School who was

> hired as a medical liaison by Warner-Lambert in 1996, alleges in court

> filings that the company was not satisfied with the limited sales

potential

> of Neurontin.

>

> To boost sales, the company illegally marketed Neurontin to physicians for

> conditions including attention deficit disorder in children, neurologic

> pain and bipolar disorder, lin said, according to the Times.

>

> The US attorney's office in Boston is holding criminal and civil

> investigations into the marketing of Neurontin, the Times said, citing

> statements made by federal prosecutors in court.

>

> Pfizer said it is cooperating with investigators and contesting the suit,

> which it does not expect to affect its finances significantly, the Times

> said.

>

> Pfizer officials could not be reached early Thursday morning for further

> comment.

>

>

>